On Tuesday, October 15th 2019, Dr. Arun Jesudian of Weill Cornell Medicine presented on:
“Current HCV Treatment”
1. Understand the prevalence of HCV and distribution of HCV genotypes.
3. Understand the advances made in the evolution of treating HCV over the past 20+ years.
4. Understand HCV genotypes and the drug regimens that work to eradicate HCV on each genotype.
Dr. Arun Jesudian is a Transplant Hepatologist in the Center for Liver Disease and Transplantation of NewYork-Presbyterian Hospital/Weill Cornell Medicine. He earned his BA from the University of Virginia where he was an Echols scholar and his MD from Virginia Commonwealth University School of Medicine where he was elected to the Alpha Omega Alpha Medical Honor Society. He then completed residency in Internal Medicine and fellowship in Gastroenterology at NewYork-Presbyterian Hospital/Weill Cornell Medical College as well as advanced fellowship training in Transplant Hepatology at NewYork-Presbyterian Hospital/Columbia University. Dr. Jesudian is the Director of Inpatient Liver Services at NYPH/Weill Cornell and also serves as a member of the Department of Medicine Quality Improvement Patient Safety Committee. His clinical research focuses on the areas of quality improvement in cirrhosis management and complications of portal hypertension.